Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Karp

Showing results (1-10 of 405) with videos related to

Pageof 41
Sort By:
American Journal of Medical Genetics|January 1, 1981
Should God take out a patient?L E Karp
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinomaS E Karp
Seminars in Hematology|August 28, 2001
Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignanciesJ E Karp
Postgraduate Medicine|May 1, 1978
Genetic individualityL E Karp
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2005
Farnesyl transferase inhibition in hematologic malignanciesJudith E Karp
The Western Journal of Medicine|April 1, 1977
Obstetrics and gynecology: efficacy and safety of prenatal genetic amniocentesisL E Karp
American Journal of Medical Genetics|April 1, 1983
Dyssyntonia chronicis (The Syncopated Biological Clock)L E Karp
American Journal of Medical Genetics|March 1, 1983
The trial of GodL E Karp
Postgraduate Medicine|February 1, 1980
Therapy of genetic diseases: a three-level approachL E Karp
American Journal of Medical Genetics|January 1, 1981
In appreciation of jumping FrenchmenL E Karp
Pageof 41

Showing results (1-10 of 405) with videos related to

Sort By:
Pageof 41
American Journal of Medical Genetics|January 1, 1981
Should God take out a patient?L E Karp
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinomaS E Karp
Seminars in Hematology|August 28, 2001
Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignanciesJ E Karp
Postgraduate Medicine|May 1, 1978
Genetic individualityL E Karp
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2005
Farnesyl transferase inhibition in hematologic malignanciesJudith E Karp
The Western Journal of Medicine|April 1, 1977
Obstetrics and gynecology: efficacy and safety of prenatal genetic amniocentesisL E Karp
American Journal of Medical Genetics|April 1, 1983
Dyssyntonia chronicis (The Syncopated Biological Clock)L E Karp
American Journal of Medical Genetics|March 1, 1983
The trial of GodL E Karp
Postgraduate Medicine|February 1, 1980
Therapy of genetic diseases: a three-level approachL E Karp
American Journal of Medical Genetics|January 1, 1981
In appreciation of jumping FrenchmenL E Karp
Pageof 41